KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Non-cash Items (2018 - 2019)

Historic Non-cash Items for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Q4 2019 value amounting to $2.1 million.

  • Amneal Pharmaceuticals' Non-cash Items fell 2029.58% to $2.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was $2.1 million, marking a year-over-year decrease of 2029.58%. This contributed to the annual value of $2.1 million for FY2019, which is 2029.58% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Non-cash Items of $2.1 million as of Q4 2019, which was down 2029.58% from $2.6 million recorded in Q4 2018.
  • Over the past 5 years, Amneal Pharmaceuticals' Non-cash Items peaked at $2.6 million during Q4 2018, and registered a low of $2.1 million during Q4 2019.